Back to Search Start Over

Sorafenib demonstrated OS benefit for advanced renal cell carcinoma.

Source :
Hem/Onc Today. 7/25/2009, Vol. 10 Issue 14, p26-26. 1/4p.
Publication Year :
2009

Abstract

The article presents information on a study which investigated the therapeutic use of sorafenib for advanced renal cell carcinoma.

Details

Language :
English
ISSN :
15260488
Volume :
10
Issue :
14
Database :
Academic Search Index
Journal :
Hem/Onc Today
Publication Type :
Periodical
Accession number :
43236224